CD274 and adrenomyeloneuropathy: Fever and flu-like symptoms are the primary reported side effects in anti-PD-L1 clinical trials [186] This might be consistent with the hypothesis that AMN is a result of oxidative stress, triggered by fever, which is related to the use of atezolizumab [205].